Md Yuzaiful Md Yusof

Chapel Allerton Hospital — United Kingdom

Medicine · Health Sciences

22h-index1.8kcitations150works1.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Systemic Lupus Erythematosus Research(75), Rheumatoid Arthritis Research and Therapies(29), Lymphoma Diagnosis and Treatment(24), Monoclonal and Polyclonal Antibodies Research(23), Chronic Lymphocytic Leukemia Research(22)

Publications150 total

Cognitive dysfunction in systemic autoimmune rheumatic diseases: a new focus for future research and a need for greater support?
Lara D. Veeken·2026
Challenges in the diagnosis of systemic lupus erythematosus
Clinical Medicine·2025· 4 citedOpen Access
POS1293 REAL-WORLD EXPERIENCE OF EFFECTIVENESS OF NON-MEDICAL SWITCH FROM ORIGINATOR TO BIOSIMILAR RITUXIMAB AND BETWEEN BIOSIMILARS IN CONNECTIVE TISSUE DISEASES AND VASCULITIS
Annals of the Rheumatic Diseases·2025Open Access
OP0266 PROTEOMIC COMPARISON OF MECHANISM OF ACTION OF BIOLOGIC THERAPIES IN SYSTEMIC LUPUS ERYTHEMATOSUS
Annals of the Rheumatic Diseases·2025Open Access
POS0325 RITUXIMAB SUPER-RESPONDERS: CHARACTERISTICS OF PATIENTS WITH MORE THAN 3 YEARS RESPONSE TO A SINGLE CYCLE OF TREATMENT
Annals of the Rheumatic Diseases·2025Open Access
OP0265 PROTEOMIC ANALYSIS IDENTIFIES NOVEL BIOMARKERS FOR THE DEVELOPMENT OF CLINICAL AUTOIMMUNITY IN ANA-POSITIVE AT-RISK INDIVIDUALS
Annals of the Rheumatic Diseases·2025Open Access
POS0677 EFFECTIVENESS AND SAFETY OF RITUXIMAB OR CYCLOPHOSPHAMIDE FOR THE TREATMENT OF SJOGREN DISEASE RELATED PERIPHERAL NEUROPATHY: A RETROSPECTIVE COHORT STUDY
Annals of the Rheumatic Diseases·2025Open Access
OP0077 Improving clinical outcomes in SLE arthritis trials: post-hoc analysis of a prospective intervention study
Annals of the Rheumatic Diseases·2025Open Access
DISCOVERY AND VALIDATION OF A NEW CLASSIFICATION OF ANA-RMDS THAT BETTER PREDICT LONG-TERM OUTCOMES COMPARED TO LEGACY DIAGNOSES
The Journal of Rheumatology·2025· 1 cited
IMPROVEMENTS OBSERVED IN SKIN AND JOINT MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS WITH DAPIROLIZUMAB PEGOL TREATMENT: RESULTS FROM A PHASE 3 TRIAL
The Journal of Rheumatology·2025Open Access
SIMILARITY AND DIVERSITY IMMUNOLOGICAL ABERRATIONS IN STABLE BENIGN IMMUNITY AND TOWARD ANA-RELATED AUTOIMMUNE DISEASES IN ANA-POSITIVE AT-RISK POPULATIONS
The Journal of Rheumatology·2025Open Access
REAL-WORLD EXPERIENCE OF EFFECTIVENESS OF NONMEDICAL SWITCH FROM ORIGINATOR TO BIOSIMILAR RITUXIMAB AND BETWEEN BIOSIMILARS IN CONNECTIVE TISSUE DISEASES AND VASCULITIS
The Journal of Rheumatology·2025
RITUXIMAB SUPER-RESPONDERS: CHARACTERISTICS OF PATIENTS WITH MORE THAN 3 YEARS RESPONSE TO A SINGLE CYCLE OF TREATMENT
The Journal of Rheumatology·2025Open Access
PERFORMANCE OF THE 2019 EULAR/ACR AND 2012 SLICC CLASSIFICATION CRITERIA FOR SLE AS DIAGNOSTIC CRITERIA
The Journal of Rheumatology·2025Open Access
P158 Effectiveness and safety of rituximab and cyclophosphamide for the treatment of Sjögren’s disease-related peripheral neuropathy: a retrospective cohort study  
Lara D. Veeken·2025Open Access
OA30 Real-world use and outcomes of avacopan for ANCA-associated vasculitis differ from clinical trials and a historical cohort: a multicentre UK cohort study
Lara D. Veeken·2025Open Access
P142 End-stage renal failure in systemic lupus erythematosus may be explained by suboptimal care delivery to high-risk patient groups
Lara D. Veeken·2025Open Access
P148 Discovery and validation of a new classification of ANA-RMDs that better predict long term outcomes compared to legacy diagnoses
Lara D. Veeken·2025Open Access
Improving the arthritis component of the SLEDAI-2K
Lara D. Veeken·2024· 1 citedOpen Access
ANA-associated arthritis: clinical and biomarker characterization of a population for basket trials
Lara D. Veeken·2024· 1 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

Edward M Vital(41), Paul Emery(34), Miriam Wittmann(13), Shouvik Dass(11), E. Hensor(11), Antonios Psarras(10), Adewonuola Alase(8), Yasser M. El‐Sherbiny(7), Andy C. Rawstron(6), Sinisa Savic(6), Maya H Buch(5), Ahmed S Zayat(5), Mark Goodfield(5), Paul Beirne(4), Katherine Dutton(4), Reuben Tooze(4), Gina M. Doody(4), Alaa Mohamed(4), Dennis McGonagle(4), Philip G. Conaghan(4)